Ondine Biomedical (OBI) Competitors C$12.58 -0.67 (-5.02%) As of 08/1/2025 12:31 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock OBI vs. HZD, FARN, VRP, AVCT, ARIX, CIR, BVXP, 4BB, TILS, and VSNShould you be buying Ondine Biomedical stock or one of its competitors? The main competitors of Ondine Biomedical include Horizon Discovery Group plc (HZD.L) (HZD), Faron Pharmaceuticals Oy (FARN), Verona Pharma plc (VRP.L) (VRP), Avacta Group (AVCT), Arix Bioscience (ARIX), Circassia Group (CIR), Bioventix (BVXP), 4basebio (4BB), Tiziana Life Sciences (TILS), and Verseon (VSN). These companies are all part of the "biotechnology" industry. Ondine Biomedical vs. Its Competitors Horizon Discovery Group plc (HZD.L) Faron Pharmaceuticals Oy Verona Pharma plc (VRP.L) Avacta Group Arix Bioscience Circassia Group Bioventix 4basebio Tiziana Life Sciences Verseon Ondine Biomedical (LON:OBI) and Horizon Discovery Group plc (HZD.L) (LON:HZD) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Is OBI or HZD more profitable? Horizon Discovery Group plc (HZD.L) has a net margin of 0.00% compared to Ondine Biomedical's net margin of -873.84%. Horizon Discovery Group plc (HZD.L)'s return on equity of 0.00% beat Ondine Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Ondine Biomedical-873.84% -684.01% -159.71% Horizon Discovery Group plc (HZD.L) N/A N/A N/A Do insiders & institutionals hold more shares of OBI or HZD? 20.6% of Ondine Biomedical shares are held by institutional investors. 36.7% of Ondine Biomedical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has preferable valuation & earnings, OBI or HZD? Horizon Discovery Group plc (HZD.L) has higher revenue and earnings than Ondine Biomedical. Ondine Biomedical is trading at a lower price-to-earnings ratio than Horizon Discovery Group plc (HZD.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOndine BiomedicalC$48.60K1,862.01-C$424.66K-C$3.32-3.79Horizon Discovery Group plc (HZD.L)£54.63M0.00N/A-£5.50N/A Does the media prefer OBI or HZD? In the previous week, Ondine Biomedical's average media sentiment score of 0.00 equaled Horizon Discovery Group plc (HZD.L)'saverage media sentiment score. Company Overall Sentiment Ondine Biomedical Neutral Horizon Discovery Group plc (HZD.L) Neutral SummaryOndine Biomedical and Horizon Discovery Group plc (HZD.L) tied by winning 4 of the 8 factors compared between the two stocks. Get Ondine Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for OBI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBI vs. The Competition Export to ExcelMetricOndine BiomedicalBiotechnology IndustryMedical SectorLON ExchangeMarket CapC$90.49MC$134.51MC$5.49BC$3.03BDividend YieldN/A3.74%4.73%5.02%P/E Ratio-3.793.8128.78176.75Price / Sales1,862.014,246.60372.20264,362.45Price / Cash1.9913.1935.4527.97Price / Book1,457.5039.388.274.53Net Income-C$424.66K-C$90.99MC$3.25BC$5.90B7 Day Performance-5.23%-1.84%-3.70%12.58%1 Month Performance-11.68%11.20%4.34%6.10%1 Year Performance53.48%189.79%25.90%71.60% Ondine Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBIOndine BiomedicalN/AC$12.59-5.0%N/A+56.8%C$90.49MC$48.60K-3.79N/AHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416FARNFaron Pharmaceuticals OyN/AGBX 197+1.0%N/A+17.2%£264.48MN/A-5.2734News CoverageVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpAVCTAvacta GroupN/AGBX 53.14-2.5%N/A-27.7%£201.89M£26.29M-6.84120News CoveragePositive NewsHigh Trading VolumeARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,650-0.9%N/A-41.5%£138.76M£13.65M17.14124BB4basebio1.8231 of 5 starsGBX 943-2.8%GBX 1,600+69.7%-34.1%£120.80M£311K-1,208.97101News CoverageTILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911VSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap Up Related Companies and Tools Related Companies Horizon Discovery Group plc (HZD.L) Competitors Faron Pharmaceuticals Oy Competitors Verona Pharma plc (VRP.L) Competitors Avacta Group Competitors Arix Bioscience Competitors Circassia Group Competitors Bioventix Competitors 4basebio Competitors Tiziana Life Sciences Competitors Verseon Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:OBI) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OBI Stock Alerts